After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

"Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Colombia President Calls Lula ‘Champion of Integration’

The president of Colombia, Àlvaro Uribe, called Brazilian President Luiz Inácio Lula da Silva, ...

Jangada Days

In Prainha Canto Verde, locals tend to view visitors not as invaders or usurpers. ...

Brazil Hopes to Lead in Alcohol Exports Thanks to Kyoto

Prospects for the sugar and alcohol sector were discussed yesterday, September 2, in Brazil, ...

Violence-Plagued Brazil Says No to Gun Control in Referendum

Brazilians are voting Sunday on a proposal to ban all gun sales in the ...

Writer’s Guidelines

Your Article and Photo BRAZZIL is always open to new articles. We are interested ...

Indians from Brazil Get Land They Had for 400 Years

The homologation of Brazil’s Raposa Serra do Sol indigenous reserve last week legitimized the ...

The damaged Legacy that collided with Boeing 737

US Pilots Association Says Brazil Air Authorities Made Terrible Mistake

The Allied Pilots Association (APA), which representing the 12,000 pilots of American Airlines, has ...

This Brazilian’s Mission: Sell Dubai as Land of Opportunity

When his ex-wife, Yasmin, moved to Dubai with the small Jeremy, in 2005, Marcelo ...

One of the ambulances sold by the Ambulances Mafia in Brazil

Ambulances, Prostitutes, Kickbacks… Here Comes the Latest Brazilian Scandal

The latest affair to rock the Brazilian republic, involving more than 100 congressmen charged ...

Despite Instability Brazil Wishes to Do Business with Bolivia

Brazilian Minister of Foreign Relations, Celso Amorim, affirmed that the relation between Brazil and ...